MiRNA profiling discriminates types of rejection and injury in human renal allografts

Transplantation

Volumn 95, Issue 6, 2013, Pages 835-841

  Wilflingseder, Julia ^a,b   Regele, Heinz ^b   Perco, Paul ^c   Kainz, Alexander ^a,b   Soleiman, Afschin ^b   Mühlbacher, Ferdinand ^b   Mayer, Bernd ^c   Oberbauer, Rainer ^a,b  

^a KH Elisabethinen ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Emergentec Biodevelopment GmbH   (Austria)

Author keywords

Acute rejection; Antibody mediated rejection; Delayed graft function; Integrative bioinformatics; miRNA

Indexed keywords

CHEMOKINE; CYTOKINE; MICRORNA; MICRORNA 106A; MICRORNA 106B; MICRORNA 125A; MICRORNA 138; MICRORNA 139 5P; MICRORNA 150; MICRORNA 155; MICRORNA 17; MICRORNA 181A; MICRORNA 181B; MICRORNA 182; MICRORNA 18A; MICRORNA 193B; MICRORNA 20A; MICRORNA 21; MICRORNA 23B; MICRORNA 27B; MICRORNA 30C 2; MICRORNA 424; MICRORNA 455; MICRORNA 502 3P; MICRORNA 574 3P; MICRORNA 638; MICRORNA 663A; MICRORNA 99B; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANGIOGENESIS; ANTIBODY MEDIATED REJECTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GENE TARGETING; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; AGED; ALGORITHM; ALLOTRANSPLANTATION; BIOPSY; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GRAFT REJECTION; INFLAMMATION; INJURY; KIDNEY; KIDNEY FAILURE; METABOLISM; METHODOLOGY; MIDDLE AGED; PROGNOSIS;

ADULT; AGED; ALGORITHMS; BIOPSY; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; INFLAMMATION; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RENAL INSUFFICIENCY; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 84877593979     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318280b385     Document Type: Article

References (48)

1. Chang SH, Russ GR, Chadban SJ, et al. Trends in kidney transplantation in Australia and New Zealand, 1993Y2004. Transplantation 2007; 84: 611.
2. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 1475.
3. Hauser P, Schwarz C, Mitterbauer C, et al. Genome-wide geneexpression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 2004; 84: 353.
4. Kainz A, Mitterbauer C, Hauser P, et al. Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant 2004; 4: 1595.
5. Mengel M, Chang J, Kayser D, et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant 2011; 11: 708.
6. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712.
7. Perco P, Kainz A, Wilflingseder J, et al. Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation 2009; 87: 290.
8. Saint-Mezard P, Berthier CC, Zhang H, et al. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transpl Int 2009; 22: 293.
9. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
10. Wilflingseder J, Kainz A, Muhlberger I, et al. Impaired metabolism in donor kidney grafts after steroid pretreatment. Tr a n s p l I n t 2010; 23: 796.
11. Chen G, Huang JB, Mi J, et al. Characterization of acute renal allograft rejection by proteomic analysis of renal tissue in rat. Mol Biol Rep 2012; 39: 1315.
12. Srivastava M, Eidelman O, Torosyan Y, et al. Elevated expression levels of ANXA11, integrins beta3 and alpha3, and TNF-alpha contribute Proteomics Clin Appl 2011; 5: 311.
13. Baek D, Villen J, Shin C, et al. The impact of microRNAs on protein output. Nature 2008; 455: 64.
14. Fessler BJ, Paliogianni F, Hama N, et al. Glucocorticoids modulate CD28 mediated pathways for interleukin 2 production in human T cells: evidence for posttranscriptional regulation. Transplantation 1996; 62: 1113.
15. Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339.
16. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009; 106: 5330.
17. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006; 313: 1929.
18. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myo-cardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980.
19. Nair VS, Maeda LS, Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 2012; 104: 528.
20. Wei Q, Bhatt K, He HZ, et al. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2010; 21: 756.
21. Stittrich AB, Haftmann C, Sgouroudis E, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010; 11: 1057.
22. Wei L, Wang M, Qu X, et al. Differential expression of microRNAs during allograft rejection. Am J Transplant 2012; 12: 1113.
23. Lee ST, Chu K, Jung KH, et al. MicroRNAs induced during ischemic preconditioning. Stroke 2010; 41: 1646.
24. Lee YJ, Johnson KR, Hallenbeck JM. Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia. PLoS One 2012; 7: e47787.
25. Harris A, Krams SM, Martinez OM. MicroRNAs as immune regulators: implications for transplantation. Am J Transplant 2010; 10: 713.
26. Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146.
27. Zhou B, Wang S, Mayr C, et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080.
28. Ni CW, Qiu H, Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 2011; 300: H1762.
29. Dai Y, Sui W, Lan H, et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009; 29: 749.
30. Te JL, Dozmorov IM, Guthridge JM, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010; 5: e10344.
31. Scian MJ, Maluf DG, David KG, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 2011; 11: 2110.
32. Basile DP, Fredrich K, Chelladurai B, et al. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol 2008; 294: F928.
33. Siedlecki AM, Jin X, Thomas W, et al. RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. Kidney Int 2011; 80: 263.
34. Favreau F, Thuillier R, Cau J, et al. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 2010; 10: 30.
35. Chen YT, Chang FC, Wu CF, et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 2011; 80: 1170.
36. Spivey TL, Uccellini L, Ascierto ML, et al. Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. J Transl Med 2011; 9: 174.
37. Kowarsch A, Preusse M, Marr C, et al. miTALOS: analyzing the tissue-specific regulation of signaling pathways by human and mouse microRNAs. RNA 2011; 17: 809.
38. Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol 17: 1169.
39. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
40. Kainz A, Wilflingseder J, Mitterbauer C, et al. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial. Ann Intern Med 2010; 153: 222.
41. Mengel M, Sis B, Haas M, et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563.
42. Grimson A, Farh KK, Johnston WK, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27: 91.
43. Maragkakis M, Alexiou P, Papadopoulos GL, et al. Accurate micro-RNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009; 10: 295.
44. Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 2006; 126: 1203.
45. Hsu SD, Lin FM, Wu WY, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011; 39: D163.
46. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25.
47. Mi H, Lazareva-Ulitsky B, Loo R, et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284.
48. Hoffmann R, Valencia A. A gene network for navigating the literature. Nat Genet 2004; 36: 664.